Insider · CIK 0001241751

BUCHEN DAVID A

Reports to the SEC for 3 companies · CORONA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001241751

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-01-03	AMRXAmneal Pharmaceuticals, Inc.F Tax Payment	SVP, Chief Legal Officer	FTax Payment	−8,188 sh	$4.72	−$38.6K	20,426
2020-01-03	AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Chief Legal Officer	MExercise/Conversion	+27.6K sh	—	—	28,614
2020-01-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	SVP, Chief Legal Officer	MExercise/Conversion	−27.6K sh	—	—	82,843
2019-01-03	AMRXAmneal Pharmaceuticals, Inc. · Stock OptionA Award	SVP, Chief Legal Officer	AAward	+227K sh	—	—	227,273
2019-01-03	AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	SVP, Chief Legal Officer	AAward	+110K sh	—	—	110,457
2015-03-05	Allergan plcF Tax Payment	See Remarks	FTax Payment	−448 sh	$295.70	−$132K	74,050
2015-03-05	Allergan plcF Tax Payment	See Remarks	FTax Payment	−269 sh	$295.70	−$79.5K	70,502
2015-03-05	Allergan plcA Award	See Remarks	AAward	+3,996 sh	—	—	74,498
2014-07-01	Allergan plcPerformance-Based Restricted Stock UnitA Award	See Remarks	AAward	+24.2K sh	—	—	24,210
2014-07-01	Allergan plcStock Option (Right to Buy)A Award	See Remarks	AAward	+22K sh	—	—	22,032
2014-07-01	Allergan plcA Award	See Remarks	AAward	+7,845 sh	—	—	70,771
2013-11-11	Allergan plcS Sale	See Remarks	SSale	−30K sh	$159.30	−$4.78M	59,966
2013-10-01	Allergan Finance LLCD Disposition to Issuer	Chief Legal Officer-Global&Sec	DDisposition to Issuer	−90K sh	—	—	0
2013-10-01	Allergan plcA Award	See Remarks	AAward	+90K sh	—	—	89,966
2013-09-30	Allergan Finance LLCA Award	Chief Legal Officer-Global&Sec	AAward	+38.4K sh	—	—	135,814
2013-09-30	Allergan Finance LLCF Tax Payment	Chief Legal Officer-Global&Sec	FTax Payment	−45.8K sh	$144.00	−$6.6M	89,966
2013-08-29	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+5,000 sh	$25.64	+$128K	107,373
2013-08-29	Allergan Finance LLCOptions to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−5,000 sh	—	—	0
2013-08-29	Allergan Finance LLCOptions to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−5,000 sh	—	—	0
2013-08-29	Allergan Finance LLCS Sale	Chief Legal Officer-Global&Sec	SSale	−10K sh	$135.56	−$1.36M	97,373
2013-08-29	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+5,000 sh	$35.11	+$176K	102,373
2013-08-12	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+16.8K sh	$26.14	+$439K	114,373
2013-08-12	Allergan Finance LLCS Sale	Chief Legal Officer-Global&Sec	SSale	−16.8K sh	$133.01	−$2.23M	97,373
2013-08-12	Allergan Finance LLCOptions to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−16.8K sh	—	—	0
2013-08-09	Allergan Finance LLCOptions to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−200 sh	—	—	0
2013-08-09	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+200 sh	$26.14	+$5,228	97,573
2013-08-09	Allergan Finance LLCS Sale	Chief Legal Officer-Global&Sec	SSale	−200 sh	$135.00	−$27K	114,173
2013-03-15	Allergan Finance LLCF Tax Payment	Chief Legal Officer-Global&Sec	FTax Payment	−933 sh	$91.59	−$85.5K	97,373
2013-03-12	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+1,600 sh	$38.92	+$62.3K	99,906
2013-03-12	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−6,400 sh	—	—	0
2013-03-12	Allergan Finance LLCS Sale	Chief Legal Officer-Global&Sec	SSale	−8,000 sh	$89.00	−$712K	98,306
2013-03-12	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−1,600 sh	—	—	0
2013-03-12	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+6,400 sh	$38.92	+$249K	106,306
2013-03-06	Allergan Finance LLCA Award	Chief Legal Officer-Global&Sec	AAward	+7,960 sh	—	—	91,590
2013-03-06	Allergan Finance LLCA Award	Chief Legal Officer-Global&Sec	AAward	+6,716 sh	—	—	98,306
2013-03-05	Allergan Finance LLCF Tax Payment	Chief Legal Officer-Global&Sec	FTax Payment	−3,896 sh	$86.46	−$337K	83,630
2013-03-02	Allergan Finance LLCF Tax Payment	Chief Legal Officer-Global&Sec	FTax Payment	−5,030 sh	$85.54	−$430K	87,526
2012-10-31	Allergan Finance LLCA Award	Chief Legal Officer-Global&Sec	AAward	+5,817 sh	—	—	92,556
2012-08-24	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+706 sh	$29.43	+$20.8K	111,033
2012-08-24	Allergan Finance LLCIncentive Stock Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−706 sh	—	—	0
2012-08-24	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+24.3K sh	$29.43	+$715K	110,327
2012-08-24	Allergan Finance LLCS Sale	Chief Legal Officer-Global&Sec	SSale	−24.3K sh	$81.56	−$1.98M	86,739
2012-08-24	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−24.3K sh	—	—	0
2012-05-25	Allergan Finance LLCF Tax Payment	Chief Legal Officer-Global&Sec	FTax Payment	−6,366 sh	$72.67	−$463K	86,033
2012-05-25	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+11.1K sh	$26.40	+$293K	88,500
2012-05-25	Allergan Finance LLCIncentive Stock Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−3,899 sh	—	—	0
2012-05-25	Allergan Finance LLCNon-Qualified Options to Purchase Common StockM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	−11.1K sh	—	—	0
2012-05-25	Allergan Finance LLCM Exercise/Conversion	Chief Legal Officer-Global&Sec	MExercise/Conversion	+3,899 sh	$26.40	+$103K	92,399
2012-03-14	Allergan Finance LLCF Tax Payment	Chief Legal Officer-Global&Sec	FTax Payment	−2,473 sh	$59.21	−$146K	77,399
2012-03-08	Allergan Finance LLCA Award	Chief Legal Officer-Global&Sec	AAward	+7,698 sh	—	—	79,872

Recent filings

Accepted (ET)
Jan 64
BUCHEN DAVID A0001723128-20-000002
SEC(opens sec.gov)
Jan 74
BUCHEN DAVID A0001723128-19-000009
SEC(opens sec.gov)
Mar 94
Actavis plc0001179110-15-004557
SEC(opens sec.gov)
Jul 34
Actavis plc0001179110-14-011536
SEC(opens sec.gov)
Nov 134
Actavis plc0001179110-13-016518
SEC(opens sec.gov)
Oct 34
Actavis plc0001179110-13-015195
SEC(opens sec.gov)
Oct 24
Actavis, Inc.0001179110-13-015050
SEC(opens sec.gov)
Sep 34
Actavis, Inc.0001179110-13-013747
SEC(opens sec.gov)

Companies

Address

C/O WATSON PHARMACEUTICALS, INC. 311 BONNIE CIRCLE

CORONA, CA, 92880